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Background: We examined the association of impaired lung function and respiratory symptoms with measures of
health status and health-related quality of life (HRQOL) among US adults.
Methods: The sample included 5139 participants aged 40–79 years in the National Health and Nutrition
Examination Survey 2007–2010 who underwent spirometric testing and responded to questions about respiratory
symptoms, health status, and number of physically unhealthy, mentally unhealthy, or activity limitation days in the
prior 30 days.
Results: Among these adults, 7.2% had restrictive impairment (FEV1/FVC ≥ 70%; FVC < 80% of predicted), 10.9%
had mild obstruction (FEV1/FVC < 70%; FEV1 ≥ 80% predicted), and 9.0% had moderate–severe obstruction (FEV1/
FVC < 70%; FEV1 < 80% predicted). Individuals with restrictive impairment or moderate–severe obstruction were
more likely to report fair/poor health compared to those with normal lung function (prevalence ratio (PR) =1.5
[95% CI: 1.2-1.9] and 1.5 [1.3-1.8]), after controlling for sociodemographics, non-respiratory chronic diseases, body
mass index, smoking, and respiratory symptoms. Frequent mental distress (FMD; ≥14 mentally unhealthy days),
frequent physical distress (FPD; ≥14 physically unhealthy days), and frequent activity limitation (FAL; ≥14 activity
limitation days) did not differ by lung function status. Adults who reported any respiratory symptoms (frequent
cough, frequent phlegm, or past year wheeze) were more likely to report fair/poor health (PR = 1.5 [1.3-1.7]),
FPD (PR = 1.6 [1.4-1.9]), FMD (PR = 1.8 [1.4-2.2]), and FAL (PR = 1.4 [1.1-1.9]) than those with no symptoms.
Conclusions: These results suggest the importance of chronic respiratory symptoms as potential risk factors for
poor HRQOL and suggest improved symptom treatment and prevention efforts would likely improve HRQOL.
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Impaired pulmonary function is common in the United
States and is often undiagnosed [1]. Approximately 14%
of US adults have some obstructive impairment of lung
function, primarily chronic obstructive pulmonary dis-
ease (COPD) and asthma while another 6% have restrict-
ive impairment, a characteristic of many interstitial
pulmonary diseases [2]. Poor health-related quality of
life (HRQOL) is common among patients diagnosed
with COPD, asthma, and other chronic respiratory
diseases [3-8]. As with other chronic illnesses, a princi-
pal goal in the management of these conditions is to
improve the quality of life of the individuals suffering
from these respiratory conditions. In order to implement
strategies to improve HRQOL, it is important to
recognize the important determinants of poor HRQOL.
Two potential contributors to poor HRQOL in respira-
tory diseases are impaired lung function, as assessed by
spirometry, and respiratory symptoms such as frequent
cough, phlegm production, or wheeze. Although pul-
monary function impairment has been found to be asso-
ciated with poor HRQOL in some studies, most studies
have been conducted among small, clinical populations
and not the general population [9-12]. In addition, most
research has not included data on respiratory symptoms,
relying primarily on spirometric measures of disease
severity [10]. Also, most studies have not evaluated the
association between respiratory symptoms and HRQOL
separately from pulmonary function; therefore they have
not been able to assess whether poor HRQOL was at-
tributable to impaired pulmonary function rather than
respiratory symptoms.
The objective of this study was to examine the inde-
pendent associations of impaired lung function and re-
spiratory symptoms with measures of health status and
HRQOL among US adults.
Methods
Study population
National Health and Nutrition Examination Survey
(NHANES) is a stratified, multistage probability sample
of the civilian non-institutionalized US population. The
survey is conducted by the National Center for Health
Statistics, Centers for Disease Control and Prevention.
Additional information is available at www.cdc.gov/
nchs/nhanes.htm. Participants are interviewed in their
homes and most subsequently complete health examin-
ation components that include medical examinations,
usually administered in mobile examination centers
(MEC). Low-income persons, persons aged ≥60 years,
Hispanics, and non-Hispanic blacks were oversampled
in 2007–2010. Many of the interviewers are bilingual
(English-Spanish), but efforts are made to obtain inter-
preters for the small minority of participants whocommunicate in languages other than English and
Spanish. Because the respiratory symptom questions
were asked only of adults aged ≥40 years and spirometry
was not performed on adults aged ≥80 years, the sample
for this study was limited to adults aged 40–79 years who
had completed baseline spirometry and responded to ques-
tions regarding respiratory symptoms in 2007–2010.
NHANES was approved by the Research Ethics Review
Board of the National Center for Health Statistics.
Pulmonary function
Pulmonary function was assessed by spirometry at the
MEC on eligible participants aged 6–79 years [13].
Examinees who reported current chest pain or had a
physical problem that may have prevented them from
forceful expiration were excluded, as were those who
were using supplemental oxygen; reported recent eye,
chest, or abdominal surgery; had a recent heart attack,
stroke, or tuberculosis exposure; had recently coughed
up blood; or reported a history of detached retina or col-
lapsed lung. Exams with questionable or invalid results
were also excluded. More details regarding spirometry
quality are also discussed in the NHANES documenta-
tion [13]. Variables obtained from spirometry and used
in this study included forced expiratory volume in 1 sec-
ond (FEV1), forced vital capacity (FVC), and the FEV1/
FVC ratio. Predicted values of FEV1 and FVC were
calculated using previously published equations [14] and
data on participants’ age, sex, height, and race/ethnicity.
The participants were classified into the following
categories: normal (FEV1/FVC ≥ 70%; FVC ≥ 80% pre-
dicted), mild obstruction (FEV1/FVC < 70%; FEV1 ≥ 80%
predicted), moderate–severe obstruction (FEV1/FVC <
70%; FEV1 <80% predicted), or restricted (FEV1/FVC ≥
70%; FVC < 80% predicted).
Chronic respiratory symptoms
During the home interview, participants aged ≥40 years
were asked if they “usually cough on most days for 3
consecutive months or more during the year”, “bring up
phlegm on most days for 3 consecutive months or more
during the year”, or “had wheezing or whistling in their
chest” in the past 12 months.
Health-related quality of life (HRQOL)
The current health status questionnaire, which included
questions on overall health status and general HRQOL,
was administered during the physical examination at the
MEC. Fair/poor health was defined as a response of fair
or poor to the question, “Would you say your health in
general is excellent, very good, good, fair, or poor?” Par-
ticipants were also asked, “Thinking about your physical
health, which includes physical illness and injury, for
how many days during the past 30 days was your
Table 1 Participants excluded from having spirometry for
safety-related reasons (N = 649)
Reason for exclusion n
Current breathing problem requiring supplemental oxygen 101
Current pain or physical problem preventing taking a deep breath 150
Coughed up blood in previous month 17
Eye surgery in previous 3 months 74
Open chest or abdominal surgery in previous 3 months 42
Stroke in previous 3 months 9
Heart attack in previous 3 months 7
Tuberculosis in previous year 21
History of aneurysm 66
History of collapsed lung 79
History of detached retina 83
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mental health, which includes stress, depression, and
problems with emotions, for how many days during the
past 30 days was your mental health not good?”; and
“During the past 30 days, for about how many days did
poor physical or mental health keep you from doing
your usual activities, such as self-care, work, school or
recreation?” The construct validity of these four HRQOL
questions has been discussed previously [15,16]. A re-
sponse of ≥14 days to each question was categorized as
frequent physical distress, frequent mental distress, and
frequent activity limitation, respectively. The 14-day cut-
off has been used in prior studies using these Healthy
Days measures and reflects the upper 10-15% of the dis-
tribution for each of these measures [17,18].
Covariates
Data were also collected regarding participants’ sex, age,
race/ethnicity (non-Hispanic white, non-Hispanic black,
Mexican-American, and other), and years of education
(<12 years, 12 years, >12 years). Participants were also
asked about chronic non-respiratory illnesses including
diabetes, arthritis, gout, current anemia, heart failure,
coronary heart disease, angina, myocardial infarction,
stroke, thyroid disease, liver disease, and any cancer, and
were categorized based on number of chronic illnesses
(0, 1–2, ≥3). Participants were also categorized by smok-
ing status (current, former, never). Participant height
and weight were measured by trained health technicians
and used to calculate body mass index (BMI) (weight
[kg]/height [m2]).
Statistical analysis
Statistical analyses were conducted using SAS 9.2 (SAS
Institute, Inc.) with SUDAAN 10.0.1 (RTI International)
to account for the complex sampling design. MEC sam-
ple weights were used. The proportion of participants
with respiratory symptoms and prevalence ratios (PR)
with 95% confidence intervals (CI) for the likelihood of
respiratory symptoms associated with lung function sta-
tus were obtained from multivariable logistic regression
analyses that were adjusted for sex, age, race/ethnicity,
education level, number of non-respiratory chronic ill-
nesses, BMI, and smoking status. The proportion of par-
ticipants with poor HRQOL measures and prevalence
ratios (PR) with 95% confidence intervals (CI) for the
likelihood of poor HRQOL associated with lung function
status and respiratory symptoms were obtained from
multivariable logistic regression analyses that also
adjusted for sex, age, race/ethnicity, education level,
number of non-respiratory chronic illnesses, BMI, and
smoking status. We investigated the effects of lung func-
tion status and respiratory symptoms both separately
(models included either lung function category orrespiratory symptoms) and simultaneously (models in-
cluded both lung function category and respiratory
symptoms). Respiratory symptoms were assessed indi-
vidually (frequent cough, frequent phlegm, or past year
wheeze) and as a binary variable (any vs. none).
Results
Out of 7296 adults aged 40–79 years who participated in
the 2007–2010 NHANES cycle, 192 did not undergo
examinations at the MECs, 1643 were excluded due
to inadequate spirometry data (safety exclusions = 649
(Table 1), unacceptable quality spirometry = 346, and did
not undergo testing for other reasons = 648), 314 were
missing at least one response to the HRQOL or respira-
tory symptoms questions, and 8 were excluded due to
missing education or BMI data. The final study sample
consisted of 5139 individuals (70.4% of the initial
sample).
Characteristics of the sample population are presented
in Table 2. Of 5139 participants, 2572 (49.0%) were men,
2231 (32.1%) were aged 60–79 years, 2566 (75.4%) were
white, and 2447 (57.7%) had >12 years education. In
addition, 9.4% reported ≥3 non-respiratory chronic ill-
nesses, 37.3% were obese (BMI ≥ 30 kg/m2), and 18.4%
were current smokers. Lung function was normal for
72.9% while 7.2% were categorized as having restrictive
impairment and 19.9% had at least mild obstruction.
The most common respiratory symptom was wheezing
in the past year (12.9%) and 21.0% reported at least one
of the three respiratory symptoms studied. Among the
participants who reported respiratory symptoms, 64%
reported only one symptom and 12% reported all three.
Fair/poor health was reported by 16.3%. Frequent
physical distress, mental distress, and activity limitation
were reported by 11.3%, 11.6%, and 5.3% of the study
population. Among participants who reported fair/poor
health, 32% also reported frequent physical distress, 25%
Table 2 Unadjusted characteristics of study population -
NHANES, 2007–2010
Characteristic Na %b (95% CI)
Total 5139 100.0
Sex
Men 2572 49.0 (47.8-50.1)
Women 2567 51.0 (49.9-52.2)
Age category (years)
40-49 1523 35.2 (32.9-37.6)
50-59 1385 32.7 (30.8-34.6)
60-69 1364 21.0 (19.6-22.4)
70-79 867 11.1 (10.3-12.0)
Race/Ethnicity
White (Non-Hispanic) 2566 75.4 (70.5-79.7)
Black (Non-Hispanic) 963 9.7 (7.7-12.1)
Mexican-American 872 6.2 (4.2-8.9)
Other/Multiracial 738 8.8 (6.8-11.3)
Education (years)
<12 1467 17.4 (15.3-19.7)
12 1225 24.9 (22.7-27.3)
>12 2447 57.7 (54.1-61.3)
Non-respiratory chronic illnessesc
None 2164 45.3 (42.4-48.2)
1-2 2395 45.3 (43.0-47.7)
≥3 580 9.4 (8.1-10.8)
BMI category
Underweight/normal (<25.0 kg/m2) 1177 25.8 (23.6-28.2)
Overweight (25.0-29.9 kg/m2) 1885 36.9 (34.6-39.2)
Obese (≥30 kg/m2) 2077 37.3 (35.1-39.5)
Smoking status
Current 1036 18.4 (16.5-20.6)
Former 1563 30.3 (28.0-32.7)
Never 2539 51.3 (48.8-53.8)
Lung function category
Normal lung function 3698 72.9 (70.8-74.8)
Restrictive impairment 438 7.2 (6.2-8.4)
Mild obstruction 524 10.9 (9.4-12.6)
Moderate–severe obstruction 479 9.0 (7.8-10.3)
Respiratory symptoms
Frequent cough 521 10.4 (9.0-12.0)
Frequent phlegm 445 7.8 (7.0-8.7)
Past year wheeze 678 12.9 (11.4-14.5)
Any symptoms 1087 21.0 (19.0-23.2)
No symptoms 4052 79.0 (76.8-81.0)
1 symptom 670 13.4 (11.9-15.2)
2 symptoms 277 5.0 (4.3-5.9)
3 symptoms 140 2.5 (2.0-3.2)
Table 2 Unadjusted characteristics of study population -
NHANES, 2007–2010 (Continued)
Characteristic Na %b (95% CI)
Health-related quality of life
Fair/poor health 1248 16.3 (14.4-18.4)
Frequent physical distressd 691 11.3 (9.7-13.1)
Frequent mental distresse 627 11.6 (10.2-13.0)
Frequent activity limitationf 322 5.3 (4.4-6.4)
a Unweighted n’s.
b Weighted percentage.
c Non-respiratory chronic diseases included diabetes, arthritis, gout, current
anemia, heart failure, coronary heart disease, angina, myocardial infarction,
stroke, thyroid disease, liver disease, and any cancer.
d Physical health not good ≥14 days during past 30 days.
e Mental health not good ≥14 days during past 30 days.
f Poor health limited usual activities ≥14 days during past 30 days.
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quent activity limitation. Of those with frequent physical
distress, less than half rated their health as fair or poor
(47%), with corresponding proportions of 35% for those
with frequent mental distress and 56% for those with
frequent activity limitations.
When compared to participants with normal lung
function, those with moderate–severe obstruction were
more likely to report frequent cough (PR = 1.63 [1.20-
2.20]), frequent phlegm (PR = 1.99 [1.31-3.03]), and
wheeze in the past year (PR = 2.65 [2.04-3.43]) (Table 3).
Report of individual respiratory symptoms was not sig-
nificantly elevated among participants with restrictive
impairment or mild obstruction, although those with re-
strictive impairment were more likely to report at least
one respiratory symptom (PR = 1.32 [1.06-1.63]). Less
than half (47.4%) of participants with moderate–severe
obstruction reported at least one of the respiratory
symptoms.
Compared to those with normal lung function, the un-
adjusted prevalences of all poor HRQOL measures were
significantly higher (p < 0.05) for those with restrictive
impairment (Table 4). With the exception of frequent
mental distress, the prevalences of poor HRQOL mea-
sures also were significantly higher for participants with
moderate–severe obstruction. Mild obstruction was not
associated with any of the HRQOL measures. After
adjusting for sociodemographic variables, number of
chronic diseases, smoking status, and BMI, only fair/
poor health remained higher for the restrictive impair-
ment and moderate–severe obstruction groups. In
contrast, prevalences of all poor HRQOL measures
remained significantly higher for those who reported any
chronic respiratory symptoms compared to asymptom-
atic individuals after adjusting for sociodemographic var-
iables, number of chronic diseases, smoking status, and
BMI. Prevalences of all poor HRQOL measures were
also significantly higher for those who reported each of
Table 3 Likelihood of respiratory symptomsa by lung
function category
%b (95% CI) Adjusted PRc
(95% CI)
Frequent cough
Normal lung function 8.6 (7.1-10.3) 1.00 –
Restrictive impairment 13.0 (8.9-18.7) 1.12 (0.75-1.66)
Mild obstruction 9.3 (6.4-13.2) 0.83 (0.53-1.29)
Moderate–severe obstruction 24.2 (18.7-30.7) 1.63 (1.20-2.20)
Frequent phlegm
Normal lung function 5.9 (5.2-6.8) 1.00 –
Restrictive impairment 10.0 (6.4-15.3) 1.14 (0.72-1.81)
Mild obstruction 9.1 (6.0-13.6) 1.21 (0.76-1.93)
Moderate–severe obstruction 19.8 (14.5-26.4) 1.99 (1.31-3.03)
Wheeze
Normal lung function 10.2 (9.0-11.5) 1.00 –
Restrictive impairment 18.5 (13.7-24.6) 1.36 (0.99-1.87)
Mild obstruction 11.8 (8.7-15.7) 1.23 (0.89-1.71)
Moderate–severe obstruction 31.9 (25.8-38.8) 2.65 (2.04-3.43)
Any respiratory symptoms
Normal lung function 17.1 (15.1-19.3) 1.00 –
Restrictive impairment 29.0 (23.8-34.8) 1.32 (1.06-1.63)
Mild obstruction 19.9 (15.8-24.8) 1.06 (0.81-1.38)
Moderate–severe obstruction 47.4 (39.9-55.0) 2.10 (1.69-2.60)
a Respiratory symptoms included the following: cough most days (at least
3 months), bring up phlegm most days (at least 3 months), or had wheeze or
whistle in chest (in past 12 months).
b Unadjusted.
c Adjusted prevalence ratio (PR) and 95% confidence interval (CI) obtained
from multivariable logistic regression that included sex, age, race/ethnicity,
education, number of non-respiratory chronic illnesses, smoking status, and
BMI as covariates.
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uals without the given symptom.
In models including both lung function category and
presence of respiratory symptoms (any versus none)
simultaneously and adjusting for sociodemographic vari-
ables, number of chronic diseases, smoking status, and
BMI, prevalence of fair/poor health remained signifi-
cantly higher for participants with restrictive impairment
(PR = 1.51 [1.20-1.90]) and moderate–severe obstruction
(PR = 1.49 [1.25-1.77]) compared to those with normal
lung function. In these fully adjusted models, all poor
HRQOL measures remained significantly higher for par-
ticipants who reported any respiratory symptoms com-
pared to asymptomatic participants (fair/poor health:
PR = 1.49 [1.30-1.71]; frequent physical distress: PR =
1.62 [1.36-1.91]; frequent mental distress: PR = 1.76
[1.40-2.22]; and frequent activity limitation: PR = 1.41
[1.07-1.85].) Since the association with HRQOL might
differ by respiratory symptom, we also performed ana-
lysis using models that included separate variables foreach symptom. When adjusting for the presence of the
other respiratory symptoms, frequent cough was not
associated with increased likelihood of any poor HRQOL
measures. Frequent phlegm was associated with increased
likelihood of fair/poor health and frequent physical distress.
Past year wheeze was associated with increased likelihood
of all poor HRQOL measures except frequent activity
limitation.Discussion
In this study, we observed that restrictive and moder-
ate–severe obstructive impairments were associated with
several measures of poor HRQOL in unadjusted models.
However, when we adjusted for chronic respiratory
symptoms and other covariates in the analyses, most of
the significant associations were attenuated or no longer
significant, with the exception of fair/poor perceived
health. On the other hand, all the HRQOL measures
were significantly associated with any self-reported re-
spiratory symptoms. These results suggest that although
both pulmonary function and respiratory symptoms may
contribute to poor HRQOL, respiratory symptoms may
disproportionately impact more aspects of HRQOL than
does pulmonary function. Aside from the mere presence
of any respiratory symptoms, we also observed different
associations between the specific symptoms and poor
HRQOL measures. When adjusting for the presence of
the other respiratory symptoms, frequent cough was no
longer associated with increased likelihood of any poor
HRQOL measures. Frequent phlegm was associated with
increased likelihood of fair/poor health and frequent
physical distress. Past year wheeze was associated with
increased likelihood of all poor HRQOL measures ex-
cept frequent activity limitation.
Some research has previously shown an association
between pulmonary function and HRQOL among pa-
tients with COPD, asthma, and other respiratory dis-
eases [3,9]. The relationship is generally stronger with
the physical component of HRQOL than the mental or
psychological component [3,7,9,11,12]. These findings
are similar to our unadjusted results, where we observed
a higher unadjusted prevalence of frequent physically
unhealthy days among adults with restrictive or moder-
ate–severe obstructive impairment, but no difference in
prevalence of frequent mental distress based on pulmon-
ary function category. However, once we adjusted for
sociodemographic variables, chronic illnesses, smoking
status, and BMI, we no longer observed a difference in
frequent physically unhealthy days by pulmonary func-
tion category. These earlier studies also did not evaluate
the association between respiratory symptoms and
HRQOL separately from pulmonary function, and were
therefore not able to ascertain how much poor HRQOL
Table 4 Prevalence and likelihood of poor health-related quality of life measures by lung function category and
presence of respiratory symptoms among US adults aged 40–79 - National Health and Nutrition Examination Survey,
2007-2010
%a (SE) Unadjusted PRa (95%CI) Adjusted PRb (95%CI) Adjusted PRc (95%CI) Adjusted PRd (95%CI)
Fair or poor health
Lung function category
Normal lung function 14.3 (1.0) 1.0 – 1.0 – 1.0 – 1.0 –
Restrictive impairment 33.1 (3.4) 2.3 (1.82-2.95) 1.6 (1.24-1.95) 1.5 (1.20-1.90) 1.5 (1.21-1.93)
Mild obstruction 11.1 (1.3) 0.8 (0.60-1.00) 1.0 (0.76-1.23) 1.0 (0.77-1.22) 1.0 (0.77-1.22)
Moderate-severe obstruction 26.0 (2.3) 1.8 (1.53-2.16) 1.6 (1.39-1.91) 1.5 (1.25-1.77) 1.5 (1.25-1.78)
Chronic respiratory symptoms
Frequent cough 28.2 (2.1) 1.9 (1.57-2.26) 1.4 (1.17-1.77) 1.1 (0.87-1.47)
No frequent cough 15.0 (1.0) 1.0 – 1.0 – 1.0 –
Frequent phlegm 33.1 (2.4) 2.2 (1.87-2.63) 1.6 (1.27-1.94) 1.3 (1.00-1.74)
No frequent phlegm 14.9 (1.0) 1.0 – 1.0 – 1.0 –
Past year wheeze 29.8 (2.5) 2.1 (1.79-2.41) 1.4 (1.21-1.73) 1.3 (1.03-1.56)
No past year wheeze 14.4 (0.9) 1.0 – 1.0 – 1.0 –
Any 28.2 (1.8) 2.1 (1.87-2.44) 1.6 (1.38-1.80) 1.5 (1.30-1.71)
None 13.2 (0.9) 1.0 – 1.0 – 1.0 –
Frequent physical distresse
Lung function category
Normal lung function 10.2 (1.0) 1.0 – 1.0 – 1.0 – 1.0 –
Restrictive impairment 18.4 (2.3) 1.8 (1.28-2.54) 1.2 (0.81-1.78) 1.2 (0.77-1.74) 1.2 (0.78-1.76)
Mild obstruction 10.2 (1.5) 1.0 (0.70-1.45) 1.1 (0.76-1.56) 1.1 (0.76-1.55) 1.1 (0.76-1.52)
Moderate-severe obstruction 15.8 (1.9) 1.6 (1.20-2.01) 1.2 (0.94-1.62) 1.1 (0.83-1.47) 1.1 (0.79-1.41)
Chronic respiratory symptoms
Frequent cough 21.7 (2.4) 2.2 (1.80-2.57) 1.6 (1.27-1.90) 1.1 (0.87-1.33)
No frequent cough 10.1 (0.7) 1.0 – 1.0 – 1.0 –
Frequent phlegm 26.8 (3.7) 2.7 (2.12-3.40) 1.9 (1.43-2.50) 1.6 (1.15-2.18)
No frequent phlegm 10.0 (0.7) 1.0 – 1.0 – 1.0 –
Past year wheeze 24.1 (2.3) 2.6 (2.07-3.18) 1.8 (1.43-2.22) 1.6 (1.21-2.08)
No past year wheeze 9.4 (0.8) 1.0 – 1.0 – 1.0 –
Any 20.5 (1.9) 2.3 (1.98-2.73) 1.6 (1.40-1.91) 1.6 (1.36-1.91)
None 8.8 (0.7) 1.0 – 1.0 – 1.0 –
Frequent mental distressf
Lung function category
Normal lung function 11.3 (0.7) 1.0 – 1.0 – 1.0 – 1.0 –
Restrictive impairment 15.7 (1.9) 1.4 (1.09-1.75) 1.2 (0.97-1.52) 1.2 (0.93-1.44) 1.2 (0.95-1.47)
Mild obstruction 9.6 (1.8) 0.8 (0.56-1.28) 1.0 (0.71-1.46) 1.0 (0.73-1.44) 1.0 (0.73-1.43)
Moderate-severe obstruction 12.5 (2.0) 1.1 (0.79-1.56) 1.0 (0.72-1.40) 0.9 (0.61-1.26) 0.9 (0.60-1.23)
Chronic respiratory symptoms
Frequent cough 22.1 (2.3) 2.1 (1.71-2.67) 1.7 (1.33-2.21) 1.4 (0.99-1.96)
No frequent cough 10.3 (0.6) 1.0 – 1.0 – 1.0 –
Frequent phlegm 22.9 (2.7) 2.2 (1.70-2.73) 1.7 (1.32-2.27) 1.3 (0.91-1.84)
No frequent phlegm 10.6 (0.6) 1.0 – 1.0 – 1.0 –
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Table 4 Prevalence and likelihood of poor health-related quality of life measures by lung function category and
presence of respiratory symptoms among US adults aged 40–79 - National Health and Nutrition Examination Survey,
2007-2010 (Continued)
%a (SE) Unadjusted PRa (95%CI) Adjusted PRb (95%CI) Adjusted PRc (95%CI) Adjusted PRd (95%CI)
Past year wheeze 21.9 (2.1) 2.2 (1.76-2.71) 1.7 (1.30-2.12) 1.5 (1.16-1.94)
No past year wheeze 10.0 (0.6) 1.0 – 1.0 – 1.0 –
Any 20.2 (1.7) 2.2 (1.78-2.68) 1.7 (1.40-2.18) 1.8 (1.40-2.22)
None 9.3 (0.6) 1.0 – 1.0 – 1.0 –
Frequent activity limitationg
Lung function category
Normal lung function 4.6 (0.6) 1.0 – 1.0 – 1.0 – 1.0 –
Restrictive impairment 9.4 (1.7) 2.0 (1.24-3.36) 1.3 (0.75-2.11) 1.2 (0.73-2.09) 1.3 (0.74-2.11)
Mild obstruction 4.7 (1.3) 1.0 (0.54-1.92) 1.1 (0.58-2.12) 1.1 (0.58-2.12) 1.1 (0.59-2.09)
Moderate-severe obstruction 8.8 (1.6) 1.9 (1.18-3.08) 1.4 (0.82-2.39) 1.3 (0.76-2.21) 1.3 (0.75-2.13)
Chronic respiratory symptoms
Frequent cough 11.2 (1.4) 2.4 (1.93-3.03) 1.5 (1.13-1.88) 1.2 (0.81-1.71)
No frequent cough 4.7 (0.4) 1.0 – 1.0 – 1.0 –
Frequent phlegm 12.6 (1.4) 2.7 (2.06-3.45) 1.5 (1.14-2.10) 1.3 (0.83-1.93)
No frequent phlegm 4.7 (0.5) 1.0 – 1.0 – 1.0 –
Past year wheeze 11.6 (1.4) 2.6 (1.97-3.49) 1.5 (1.07-2.10) 1.3 (0.92-1.94)
No past year wheeze 4.4 (0.5) 1.0 – 1.0 – 1.0 –
Any 10.1 (1.1) 2.5 (1.91-3.19) 1.4 (1.09-1.92) 1.4 (1.07-1.85)
None 4.1 (0.4) 1.0 – 1.0 – 1.0 –
a Unadjusted.
b Prevalence ratio (PR) and 95% confidence interval (CI) obtained from multivariable logistic regression models that included either lung function category or
presence of any respiratory symptoms, as well as sex, age, race/ethnicity, education, number of non-respiratory chronic illnesses, smoking status, and BMI.
c Prevalence ratio (PR) and 95% confidence interval (CI) obtained from multivariable logistic regression model that included both lung function category and presence of
any respiratory symptoms simultaneously and was adjusted for sex, age, race/ethnicity, education, number of non-respiratory chronic illnesses, smoking status, and BMI.
d Prevalence ratio (PR) and 95% confidence interval (CI) obtained from multivariable logistic regression model that included both lung function category and each
respiratory symptom simultaneously and was adjusted for sex, age, race/ethnicity, education, number of non-respiratory chronic illnesses, smoking status, and BMI.
e Physical health not good ≥14 days during past 30 days.
f Mental health not good ≥14 days during past 30 days.
g Poor health limited usual activities ≥14 days during past 30 days.
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respiratory symptoms.
Our findings regarding respiratory symptoms are sup-
ported by several other studies. In an Australian adult
population cohort, chronic cough was more common
among those with severe psychological disturbance. This
result persisted when the analyses were limited to indi-
viduals without identifiable respiratory disease and non-
smokers. Compared to those without chronic cough at
any time, adults reporting cough at follow-up were more
likely to report more severe psychological disturbance,
as well as poorer HRQOL (both physical and mental
components) [19]. Another population study in Norway
(N = 2306) showed that after adjustment for respiratory
symptoms, the physical component scale score was
significantly lower (worse) in individuals with severe
COPD, and the mental component scale score was
significantly higher (better) in individuals with COPD
[3]. Similar to our study, both physical and mentalcomponents of HRQOL were negatively impacted by
respiratory symptoms. The primary focus of that study
was COPD and restrictive impairment and other ob-
structive impairment were not evaluated [3]. Among
Swedish patients with asthma, symptom severity was as-
sociated with worse physical and mental well-being
among women but not among men [20]. Other studies
have found that respiratory symptoms were related to
poorer HRQOL among COPD, asthma, and sarcoidosis
patients, while pulmonary function was not [8,21].
Finally, in the European Community Respiratory Health
Survey, individuals with respiratory symptoms had
poorer physical and mental HRQOL even in the absence
of asthma and COPD and after adjustment for bronchial
hyperresponsiveness and FEV1 [22].
Mild obstruction was not associated with any HRQOL
measures in our study. Likewise, asymptomatic mild
obstruction was not associated with poorer HRQOL in a
Swiss cohort when compared to asymptomatic individuals
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atic mild obstruction not only had poorer HRQOL, they
also had a faster decline in FEV1 and greater utilization of
respiratory care [23]. This further emphasizes the import-
ance of respiratory symptoms in overall health. In another
study, individuals with mild obstruction were more likely to
have depressive symptoms than adults without obstruction
[4]. Unfortunately, data regarding respiratory symptoms
was not included in that analysis. Since these individuals
were selected for that study because they had been treated
for COPD in the previous year, it is possible that they had
more respiratory symptoms than if they had been selected
from the general population.
The HRQOL questions used in this study were devel-
oped by CDC to provide generic measures of HRQOL
rather than condition-specific measures in order to allow
comparison across all population age groups and chronic
conditions. They have been validated in general popula-
tions as well as numerous subpopulations and various
conditions [18,24-26]. These measures are comparable
to subscales of other generic HRQOL instruments such
as the Medical Outcomes Study Short Form-36 [27].
Although there is some literature on the association
of pulmonary function and respiratory symptoms with
HRQOL using condition-specific questionnaires such as
the St. George’s Respiratory Questionnaire and the
Airways Questionnaire 20, items used to assess the
presence or severity of respiratory symptoms are over-
represented and therefore do not assess global measures
of physical and mental health.
There are some limitations to this study. First, this was
a cross-sectional study. Therefore, we cannot determine
causality in the association between pulmonary function,
respiratory symptoms, and HRQOL. Although adverse
respiratory health likely leads to poor HRQOL, it is also
possible that poor HRQOL could lead to worse manage-
ment of symptoms or to behaviors that might be
detrimental to respiratory health. Second, symptoms in-
cluded in the questionnaire were limited. One important
symptom that was not addressed was shortness of breath
or dyspnea. The respiratory symptoms questions were
also asked of a limited age group (aged ≥40 years).
Therefore, our results may not be generalizable to youn-
ger populations.
Another limitation of this study lay in the large pro-
portion of adults without spirometric results who were
omitted from our analyses. There were 1224 adults with
complete data on symptoms, HRQOL measures, and
confounders, but missing spirometry data. Of these, 592
were safety exclusions, 315 underwent spirometric test-
ing but of insufficient quality, and 317 did not undergo
testing for other reasons such as participant refusal or
time limitations. Compared to the study population, the
safety exclusions were older, had more chronic illnesses,and were more likely to have a history of smoking. Simi-
larly to the moderate-severe obstruction group, this
group had a higher likelihood of reporting frequent
cough, frequent phlegm, and past year wheeze. The per-
sons who underwent spirometry but with insufficient
quality results were also older, but were more likely to
be of minority ethnic/racial groups, and to be never
smokers. This group had a higher likelihood of reporting
past year wheeze, but not frequent cough or frequent
phlegm, than those with normal lung function. Partici-
pants excluded for other reasons were more predomin-
antly female and had a higher proportion of minority
ethnic/racial groups. This group also had a higher likeli-
hood of reporting past year wheeze, but not frequent
cough or frequent phlegm, than those with normal lung
function. All three groups excluded from our analyses
due to inadequate or no spirometry data had a higher
likelihood of reporting fair/poor health, frequent phys-
ical distress, and frequent activity limitation (in fully ad-
justed models) than adults with normal lung function.
The safety exclusion group also had a higher prevalence
of frequent mental distress. Many of the participants in
the safety exclusion group likely had severe lung func-
tion impairment, such as might require supplemental
oxygen (see Table 1), but other problems may not have
been associated with poor lung function at all.Conclusions
When respiratory symptoms were taken into account,
pulmonary function was associated only with perceived
fair/poor health. Respiratory symptoms, however, were
strongly associated with all HRQOL measures. Most of
this association appears to be attributable to frequent
phlegm and past year wheeze. More than one quarter of
the adults in this survey were identified to have some
pulmonary dysfunction, while nearly one quarter of the
adults in this survey reported at least one respiratory
symptom including 20% of adults with normal lung
function. Given the high prevalence of respiratory prob-
lems in the population, additional research is necessary
to determine if diagnosis and treatment of pulmonary
dysfunction or treatment of respiratory symptoms in the
general population will improve HRQOL.
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